home1_b

TRIANNI and Antibody Discovery

Fully human monoclonal antibodies are powerful biological therapeutics.

Among many options available for isolating them, TRIANNI’s technology is distinguished by key advantages of ease of use, antibody diversity, and in vivo selection.

partnering
events

Biologics & Biosimilars Congress

PRESENTER
March 6–7, 2017  |  Berlin, Germany

PEGS Summit – Boston

PRESENTER
May 1–5, 2017  |  Boston, MA, USA

American Antibody Congress

PRESENTER
May 23–24, 2017  |  San Diego, CA, USA

Save

Save

Save

Save

Save

Save

Save

Save